These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28199742)

  • 21. ALK-rearranged renal cell carcinomas in Polish population.
    Gorczynski A; Czapiewski P; Korwat A; Budynko L; Prelowska M; Okon K; Biernat W
    Pathol Res Pract; 2019 Dec; 215(12):152669. PubMed ID: 31677810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, immunohistochemistry, and real-time quantitative RT- PCR on paraffin-embedded tissues.
    Zhang YG; Jin ML; Li L; Zhao HY; Zeng X; Jiang L; Wei P; Diao XL; Li X; Cao Q; Tian XX
    PLoS One; 2013; 8(5):e64821. PubMed ID: 23741400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of Renal Cell Carcinoma Harboring
    Woo CG; Yun SJ; Son SM; Lim YH; Lee OJ
    Yonsei Med J; 2020 Mar; 61(3):262-266. PubMed ID: 32102128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene.
    Kusano H; Togashi Y; Akiba J; Moriya F; Baba K; Matsuzaki N; Yuba Y; Shiraishi Y; Kanamaru H; Kuroda N; Sakata S; Takeuchi K; Yano H
    Am J Surg Pathol; 2016 Jun; 40(6):761-9. PubMed ID: 26848800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH.
    Xia QY; Wang XT; Ye SB; Wang X; Li R; Shi SS; Fang R; Zhang RS; Ma HH; Lu ZF; Shen Q; Bao W; Zhou XJ; Rao Q
    Histopathology; 2018 Apr; 72(5):786-794. PubMed ID: 29148086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.
    Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y
    Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.
    Ying J; Lin C; Wu J; Guo L; Qiu T; Ling Y; Shan L; Zhou H; Zhao D; Wang J; Liang J; Zhao J; Jiao Y; Lu N; Zhao H
    PLoS One; 2015; 10(12):e0144731. PubMed ID: 26678488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALK-rearranged renal cell carcinoma with nuclear mitotic apparatus protein 1 (NUMA1) as a fusion partner.
    Gupta S; Krishna M; Cheville JC
    Hum Pathol; 2024 Jul; 149():75-76. PubMed ID: 38670236
    [No Abstract]   [Full Text] [Related]  

  • 29. ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology.
    Hang JF; Chung HJ; Pan CC
    Virchows Arch; 2020 Jun; 476(6):921-929. PubMed ID: 31993771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.
    Debelenko LV; Raimondi SC; Daw N; Shivakumar BR; Huang D; Nelson M; Bridge JA
    Mod Pathol; 2011 Mar; 24(3):430-42. PubMed ID: 21076462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients.
    Lee C; Park JW; Suh JH; Nam KH; Moon KC
    Korean J Pathol; 2013 Oct; 47(5):452-7. PubMed ID: 24255633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review.
    Kathuria-Prakash N; Lopez LP; Raman S; Ye H; Anaokar J; Sisk A; Pantuck AJ; Drakaki A
    JCO Precis Oncol; 2024 Jun; 8():e2400154. PubMed ID: 38885453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma.
    Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Daa T; Watanabe D; Akita Y; Sato F; Mimata H; Yokoyama S
    Pathol Int; 2017 Dec; 67(12):626-631. PubMed ID: 29024210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan.
    Wu YC; Chang IC; Wang CL; Chen TD; Chen YT; Liu HP; Chu Y; Chiu YT; Wu TH; Chou LH; Chen YR; Huang SF
    PLoS One; 2013; 8(8):e70839. PubMed ID: 23951022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations.
    Zheng D; Wang R; Zhang Y; Pan Y; Cheng X; Cheng C; Zheng S; Li H; Gong R; Li Y; Shen X; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):833-43. PubMed ID: 26646246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation.
    Thorner PS; Shago M; Marrano P; Shaikh F; Somers GR
    Pathol Res Pract; 2016 Oct; 212(10):937-942. PubMed ID: 27450657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
    Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma.
    Chen W; Li W; Bai B; Wei H
    Oncol Rep; 2020 Mar; 43(3):817-826. PubMed ID: 32020234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF; Tong JH; Yeung KS; Lung RW; Law PP; Chau SL; Kang W; Tong CY; Chow C; Chan AW; Leung LK; Mok TS
    J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.